IndraLab

Statements



reach
"Hydroxychloroquine therapy was initiated to prevent antiphospholipid antibody syndrome recurrence in a future pregnancy."

reach
"Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome [ 30 ] and is associated with lower odds of persistently positive aPL [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"A study by Bertolaccini et al. found that HCQ prevents placental ischemia and abnormal foetal brain development in mice models for antiphospholipid syndrome by inhibiting complement activation (Bertolaccini et al., 2016)."